Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 86.89% is 215% above its 5-year average of 27.62%, near the high end of its 5-year range (-32.46%–94.75%).
395.52% above its 12-month average of 17.54%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): -3.54%.
GROSS MARGIN
86.89%
GROSS MARGIN AVG TTM
17.54%
GROSS MARGIN AVG 3Y
31.11%
GROSS MARGIN AVG 5Y
27.62%
GROSS MARGIN AVG 10Y
25.64%
GROSS MARGIN AVG 15Y
27.11%
GROSS MARGIN AVG 20Y
38.23%
CURRENT VS TTM AVG
+395.52%
CURRENT VS 3Y AVG
+179.32%
CURRENT VS 5Y AVG
+214.56%
CURRENT VS 10Y AVG
+238.83%
CURRENT VS 15Y AVG
+220.50%
CURRENT VS 20Y AVG
+127.27%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+109.98%
vs the sector median at left
Market Cap
$210.80M
Gross Margin
83.89%
TTM Avg
91.94%
3Y Avg
70.97%
5Y Avg
47.31%
Market Cap
$213.92M
Gross Margin
-31952.78%
TTM Avg
-15926.39%
3Y Avg
-7913.19%
5Y Avg
-5242.13%
Market Cap
$214.24M
Gross Margin
64.24%
TTM Avg
63.06%
3Y Avg
61.57%
5Y Avg
61.22%
Market Cap
$214.64M
Gross Margin
85.91%
TTM Avg
92.95%
3Y Avg
46.48%
5Y Avg
30.98%
Market Cap
$214.85M
Gross Margin
87.24%
TTM Avg
79.57%
3Y Avg
65.64%
5Y Avg
63.99%
Market Cap
$206.11M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Compugen Ltd. (CGEN) | $211.80M | 86.89% | 17.54% | 31.11% | 27.62% |
| Entrada Therapeutics, Inc. (TRDA)vs › | $210.80M | 83.89% | 91.94% | 70.97% | 47.31% |
| Lyell Immunopharma, Inc. (LYEL)vs › | $213.92M | -31952.78% | -15926.39% | -7913.19% | -5242.13% |
| Niagen Bioscience Inc (NAGE)vs › | $214.24M | 64.24% | 63.06% | 61.57% | 61.22% |
| Prelude Therapeutics Incorporated (PRLD)vs › | $214.64M | 85.91% | 92.95% | 46.48% | 30.98% |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $214.85M | 87.24% | 79.57% | 65.64% | 63.99% |
| Pro-Dex, Inc. (PDEX)vs › | $207.94M | 31.38% | 30.34% | 28.84% | 29.64% |
| Electra Therapeutics Inc. (ETRA)vs › | $208.98M | N/A | N/A | N/A | N/A |
| Sionna Therapeutics, Inc. (SION)vs › | $206.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Whitehawk Therapeutics Inc (WHWK)vs › | $205.52M | 89.36% | -9.34% | -63.64% | -318.96% |
Gross Margin
86.9%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | -3.54% |
| 2026-03-31 | 16.18% |
| 2025-12-31 | 94.75% |
| 2025-09-30 | 12.74% |
| 2025-06-30 | -32.46% |
| 2025-03-31 | -5.08% |
| 2024-12-31 | 54.11% |
| 2024-09-30 | 78.98% |
| 2024-06-30 | 76.84% |
| 2024-03-31 | 17.86% |
| 2023-12-31 | 94.01% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 87.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 88.67% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 97.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 91.23% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 96.50% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 33.96% |
| 2016-09-30 | 70.00% |
| 2016-06-30 | 82.66% |
| 2016-03-31 | 12.90% |
| 2015-12-31 | 87.54% |
| 2015-09-30 | 12.23% |
| 2015-06-30 | 33.63% |
| 2015-03-31 | 25.54% |
| 2014-12-31 | 84.94% |
| 2014-09-30 | 56.87% |
| 2014-06-30 | 56.26% |
| 2014-03-31 | 64.51% |
| 2013-12-31 | 54.37% |
| 2013-09-30 | 7.86% |
| 2013-06-30 | -281.82% |
| 2013-03-31 | 7.41% |
| 2012-12-31 | -25.37% |
| 2012-09-30 | 69.44% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 200.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 86.32% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 75.25% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 97.51% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 100.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 100.00% |
| 2006-03-31 | 97.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 90.54% |
| 2005-06-30 | 87.97% |
| 2005-03-31 | 97.80% |
| 2004-12-31 | 85.14% |
| 2004-09-30 | 69.93% |
| 2004-06-30 | 73.37% |
| 2004-03-31 | 69.47% |
| 2003-12-31 | 60.40% |
| 2003-09-30 | 80.48% |
| 2003-06-30 | 74.85% |
| 2003-03-31 | 76.08% |
| 2002-12-31 | 75.52% |
| 2002-09-30 | 70.40% |
